HBK Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

HBK Investments’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,978,967	Closed	-$923M	–	302
2023 Q3	$923M	Buy	7,978,967 +1,928,967	+32%	+$207M	4.83%	4
2023 Q2	$622M	Buy	6,050,000 +150,000	+3%	+$15.8M	3.35%	3
2023 Q1	$644M	Buy	5,900,000 +1,324,000	+29%	+$146M	4.11%	3
2022 Q4	$521M	Buy	+4,576,000	New	+$380M	21.96%	1
2019 Q2	–	Sell	-419,047	Closed	-$11.1M	–	1219
2019 Q1	$11.1M	Buy	419,047 +36,557	+10%	+$866K	0.11%	147
2018 Q4	$7.47M	Buy	382,490 +149,585	+64%	+$2.93M	0.08%	199
2018 Q3	$4.56M	Sell	232,905 -14,995	-6%	-$285K	0.04%	316
2018 Q2	$4.11M	Sell	247,900 -98,224	-28%	-$1.5M	0.03%	313
2018 Q1	$4.92M	Buy	346,124 +328,424	+1,856%	+$4.85M	0.03%	279
2017 Q4	$258K	Buy	+17,700	New	+$249K	﹤0.01%	886
2017 Q1	–	Sell	-115,504	Closed	-$1.87M	–	878
2016 Q4	$1.87M	Sell	115,504 -105,496	-48%	-$1.91M	0.02%	350
2016 Q3	$4.01M	Buy	+221,000	New	+$4.32M	0.04%	249
2015 Q2	–	Sell	-82,359	Closed	-$2.14M	–	1175
2015 Q1	$2.14M	Buy	+82,359	New	+$1.51M	0.02%	392

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HBK Investments's HZNP Position: Q4 2023 in Review

HBK Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 7,978,967 shares — an estimated $923M sold.

HBK Investments first reported a position in HZNP in Q1 2015 and held it in 13 quarters. The position peaked at $923M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

HBK Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
HBK Investments sold 7,978,967 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $923M.
HBK Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2015 and held it in 13 quarters.
HBK Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $923M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on HBK Investments's 13F filing for Q4 2023, filed 14 Feb 2024.